Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMX-049 in Type 2 Diabetes with Albuminuria
NCT03449199Phase 2Completed
- Sponsor
- Teijin
- Start
- Apr 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TMX-049 in diabetic kidney disease (DKD), sponsored by Teijin. Started Apr 2018; status: completed.
02
Drugs
TMX-049
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT03449199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03449199.